Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2024)

Top pharmaceutical retailer stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

According to Zen Score, the 3 best drug store stocks to buy right now are:

Petmed Express (NASDAQ:PETS) is the top pharmaceutical retailer stock with a Zen Score of 26, which is 6 points higher than the pharmaceutical retailer industry average of 20. It passed 10 out of 38 due diligence checks and has average fundamentals. Petmed Express has seen its stock lose -73.1% over the past year, overperforming other pharmaceutical retailer stocks by 3 percentage points.

Petmed Express has an average 1 year price target of $6.50, an upside of 54.03% from Petmed Express's current stock price of $4.22.

Petmed Express stock has a consensus Strong Sell recommendation according to Wall Street analysts. Of the 1 analyst covering Petmed Express, 0% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 100% have issued a Strong Sell.

Trxade Health (NASDAQ:MEDS) is the second best pharmaceutical retailer stock with a Zen Score of 26, which is 6 points higher than the pharmaceutical retailer industry average of 20. It passed 9 out of 38 due diligence checks and has average fundamentals. Trxade Health has seen its stock return 56.05% over the past year, overperforming other pharmaceutical retailer stocks by 132 percentage points.

High Tide (NASDAQ:HITI) is the third best pharmaceutical retailer stock with a Zen Score of 25, which is 5 points higher than the pharmaceutical retailer industry average of 20. It passed 8 out of 33 due diligence checks and has weak fundamentals. High Tide has seen its stock return 64.71% over the past year, overperforming other pharmaceutical retailer stocks by 141 percentage points.

High Tide has an average 1 year price target of $4.50, an upside of 100.89% from High Tide's current stock price of $2.24.

High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

Trxade Health (NASDAQ:MEDS) has an annual dividend yield of 112.99%, which is 67 percentage points higher than the pharmaceutical retailer industry average of 45.6%.

Trxade Health's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 9.59%, which is -36 percentage points lower than the pharmaceutical retailer industry average of 45.6%. Walgreens Boots Alliance's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Walgreens Boots Alliance's dividend has not shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -24.1% indicates that its high dividend yield might not be sustainable for the long-term.

Pharmaceutical retailer stocks were down -0.07% in the last day, and down -7.4% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are down.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

Petmed Express (NASDAQ:PETS) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Petmed Express has a valuation score of 43, which is 32 points higher than the pharmaceutical retailer industry average of 11. It passed 3 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -73.1% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 3 percentage points.

Trxade Health (NASDAQ:MEDS) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Trxade Health has a valuation score of 14, which is 3 points higher than the pharmaceutical retailer industry average of 11. It passed 1 out of 7 valuation due diligence checks.

Trxade Health's stock has gained 56.05% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 132 percentage points.

Walgreens Boots Alliance (NASDAQ:WBA) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Walgreens Boots Alliance has a valuation score of 14, which is 3 points higher than the pharmaceutical retailer industry average of 11. It passed 1 out of 7 valuation due diligence checks.

Walgreens Boots Alliance's stock has dropped -50.95% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 25 percentage points.